Immunoadsorber for use in sepsis therapy

   
   

The invention relates to immunoadsorbers for use in sepsis therapy, in particular for removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use.

La invención se relaciona con los immunoadsorbers para el uso en terapia del sepsis, en el detalle para el retiro de los factores del complemento y los lipopolysaccharides (LPS) y, si sean la necesidad, mediadores más futuros del sepsis tales como TNF y los interleukins de los fluídos corporales, los métodos para su producción y su uso.

 
Web www.patentalert.com

< Cytokine receptor common gamma chain like

< Human FGF-20 gene and gene expression products

> Pharmaceutical composition useful in the treatment of peptic ulcers

> Compositions and methods relating to breast specific genes and proteins

~ 00174